NCT06612411View on ClinicalTrials.gov

B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Irritable Bowel Syndrome with DiarrheaPurine Metabolism Disorder
Interventions
DRUG

B. subtilis

2 capsules, 3 times a day, orally taken for one month

DRUG

Dead B. subtilis

2 capsules, 3 times a day, orally taken for one month

Trial Locations (2)

Unknown

RECRUITING

Jinling Hospital, Nanjing

RECRUITING

Jinling Hospital, Nanjing

All Listed Sponsors
lead

Jinling Hospital, China

OTHER